Increased depressive behaviour in mice harboring the mutant thyroid hormone receptor alpha 1

Behavioural Brain Research

Volumn 214, Issue 2, 2010, Pages 187-192

  Pilhatsch, Maximilian ^a   Winter, Christine ^a,b   Nordström, Kristina ^c   Vennström, Björn ^c   Bauer, Michael ^a   Juckel, Georg ^d  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c KAROLINSKA INSTITUTE   (Sweden)

^d RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Anxiety; Depression; Hypothyroidism; Mice; Thyroid receptor 1

Indexed keywords

LIOTHYRONINE; THYROID HORMONE RECEPTOR ALPHA; THYROID HORMONE RECEPTOR ALPHA 1; UNCLASSIFIED DRUG;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DEPRESSION; FEMALE; HELPLESSNESS; HETEROZYGOSITY; HORMONE SUBSTITUTION; HYPERTHYROIDISM; HYPOTHYROIDISM; LIGHT DARK CYCLE; LOCOMOTION; MOUSE; MUTANT; NONHUMAN; OPEN FIELD TEST; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; STARTLE REFLEX; WILD TYPE;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; DEPRESSION; DISEASE MODELS, ANIMAL; FEMALE; HETEROZYGOTE; HORMONE REPLACEMENT THERAPY; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; THYROID HORMONE RECEPTORS ALPHA; TRIIODOTHYRONINE;

EID: 77955272638     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2010.05.016     Document Type: Article

References (35)

1. Alvarez E.O., Beauquis J., Revsin Y., Banzan A.M., Roig P., De Nicola A.F., Saravia F. Cognitive dysfunction and hippocampal changes in experimental type 1 diabetes. Behav Brain Res 2008, 198(1):224-230.
2. Bauer M., Berghöfer A., Bschor T., Baumgartner A., Kiesslinger U., Hellweg R., Adli M., Baethge C., Müller-Oerlinghausen B. Supraphysiological doses of l-thyroxine in the maintenance treatment of prophylaxis-resistant affective disorders. Neuropsychopharmacology 2002, 27:620-628.
3. Bauer M., Heinz A., Whybrow P.C. Thyroid hormones, serotonin and mood: of synergy and significance in the adult brain. Mol Psychiatry 2002, 7:140-156.
4. Bauer M., London E.D., Rasgon N., Berman S.M., Frye M.A., Altshuler L., Mandelkern M.A., Bramen J., Woods R., Mazziotta J.C., Whybrow P.C. Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in women with bipolar disorder. Mol Psychiatry 2005, 10(5):456-469.
5. Bauer M., London E.D., Silverman D.H., Rasgon N., Kirchheiner J., Whybrow P.C. Thyroid, brain and mood modulation in affective disorder: insights from molecular research and functional brain imaging. Pharmacopsychiatry 2003, 36(Suppl 3):S215-S221.
6. Bauer M., Szuba M.P., Whybrow P.C. Psychiatric and behavioural manifestations of hyper- and hypothyroidism. Psychoneuroendocrinology: the scientific basis of clinical practice 2003, 419-444. American Psychiatric Press, Inc., Washington DC. O.M. Wolkowitz, T.J. Rothschild (Eds.).
7. Bauer M., Whybrow P.C. Thyroid hormone, brain, and behaviour. Hormones, brain and behaviour 2002, vol. 2:239-264. Academic Press, San Diego.
8. Bauer M., Silvermann H.S., Schlagenhauf F., London C., Geist C.L., van Herle K., Rasgon N., Martinez D., Miller K., van Herle A., Berman S.M., Phelps M.E., Whybrow P.C. Brain glucose metabolism in hypothyroidism: a positron emission tomography study before and after thyroid hormone replacement therapy. J Clin Endocrinol Metab 2009, 94(8):2922-2929.
9. Bernal J. Thyroid hormones and brain development. Hormones, brain and behaviour 2002, vol. 4:543-587. Academic Press, San Diego.
10. Bouwknecht J.A., Hijzen T.H., van der Gugten J., Dirks A., Maes R.A., Hen R., Geyer M.A., Olivier B. Startle responses, heart rate, and temperature in 5-HT1B receptor knockout mice. Neuroreport 2000, 11(18):4097-4102.
11. Boyd J.H., Weissmann M.M. Epidemiology of affective disorders. A re-examination and future directions. Arch Gen Psychiatry 1981, 38(9):1039-1046.
12. Chourbaji S., Zacher C., Sanchis-Segura C., Dormann C., Vollmayr B., Gass P. Learned helplessness: validity and reliability of depressive-like states in mice. Brain Res Brain Res Protoc 2005, 16(1-3):70-78.
13. Fernandez-Terual A., Escorihuela R.M., Boix F., Tobena A. Effects of different jandling-stimulation procedures and benzodiazepines on two-way active avoidance acquisition in rats. Pharmacol Res 1991, 24(3):273-282.
14. Fukui M., Rodriguiz R.M., Zhou J., Jiang S.X., Phillips L.E., Caron M.G., Wetsel W.C. Vmat2 heterozygous mutnant mice display a depressive like phenotype. J Neurosci 2007, 27(39):10520-10529.
15. Guadano-Ferraz A., Benavides-Piccione R., Venero C., Lancha C., Vennstrom B., Sandi C., DeFelipe J., Bernal J. Lack of thyroid hormone receptor alpha1 is associated with selective alterations in behaviour and hippocampal circuits. Mol Psychiatry 2003, 8:30-38.
16. Hyde L., Denenberg V. Lack of shuttlebox avoidance learning in autoimmuns bxsb mice: a test of learned heplessness. Prog Neuropsychopharmacol Biol Psychiatry 1997, 21(6):1019-1030.
17. Kalueff A.V., Keisala T., Minasyan A., Kuuslahti M., Tuohimaa P. Temporal stability of novelty exploration in mice exposed to different open field tests. Behav Processes 2006, 72(1):104-112.
18. Mombereau C., Kaupmann K., Gassmann M., Bettler B., van der Putten H., Cryan J.F. Altered anxiety and depression-related behaviour in mice lacking GABAB(2) receptor subunits. Neuroreport 2005, 16(3):307-310.
19. Nishino T., Takeushi T., Takeshi K., Kamei C. Evaluation of anxiolytic-like effects of some short-acting benzodiazepine hypnotics in mice. J Pharmacol Sci 2008, 107:349-354.
20. Pavone F., Capone F., Battaglia M., Sansone M. Shuttle-box avoidance learning in mice: improvement by combined glucose and tacrine. Neurobiol Learn Mem 1998, 69:204-210.
21. Reif A., Schmitt A., Fritzen S., Chourbaji S., Bartsch C., Urani A., Wycislo M., Mossner R., Sommer C., Gass P., Lesch K.P. Differential effect of endothelial nitric oxide synthase (NOS-III) on the regulation of adult neurogenesis and behaviour. Eur J Neurosci 2004, 20(4):885-895.
22. Raikova G., OóDwyer G., Teleki Z., Stockmaier C., Miquel-Hidalgo J. Gabaergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression. Neuropsychopharmocology 2007, 32:471-482.
23. Redei E.E., Solberg L.C., Kluczynski J.M., Pare W.P. Paradoxical hormonal and behavioural responses to hypothyroid and hyperthyroid states in the Witstar-Kyoto rat. Neuropsychopharmacology 2001, 24(6):632-639.
24. Redondo P., Guzmán M., Marquina M., Pretel M., Aguado L., Lloret P., Gorrochategui A. Repigmentation of gray hair after thyroid hormone treatment. Actas Dermosifiliogr 2007 Nov, 98(9):603-610.
25. Risbrough V.B., Hauger R.L., Pelleymounter M.A., Geyer M.A. Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice. Psychopharmacology (Berl) 2003, 170(2):178-187.
26. Sabino V., Cottone P., Parylak S.L., Steardo L., Zorrilla E.P. Sigma-1 receptor knockout mice display a depressive-like phenotype. Behav Brain Res 2009, 198(2):472-476.
27. Samuels M.H., Schuff K.G., Carlson N.E., Carello P., Janowsky J.S. Health status, mood, and cognition in experimentally induced subclinical thyrotoxicosis. J Clin Endocrinol Metab 2008 May, 93(5):1730-1736. Epub 2008 Feb 19.
28. Ströhle A. The neuroendocrinology of stress and the pathophysiology and therapy of depression and anxiety. Nervenarzt 2003, 74(3):279-291.
29. Sullivan G.M., Hatterer J.A., Herbert J., Chen X., Roose S.P., Attia E., Mann J.J., Marangell L.B., Goetz R.R., Gorman J.M. Low levels of transthyretin in the CSF of depressed patients. Am J Psychiatry 1999, 156:710-715.
30. Tinnikov A., Nordstrom K., Thoren P., Kindblom J.M., Malin S., Rozell B., Adams M., Rajanayagam O., Pettersson S., Ohlsson C., Chatterjee K., Vennstrom B. Retardation of post-natal development caused by a negatively acting thyroid hormone receptor alpha 1. EMBO J 2002, 21:5079-5087.
31. Venero C., Guadano-Ferraz A., Herrero A.I., Nordstrom K., Manzano J., De Escobar G.M., Bernal J., Venstrom B. Anxiety, memory impairment, and locomotor dysfunction caused by a mutant thyroid hormone receptor alpha 1 can be amelioratedby T3 treatment. Genes Dev 2005, 19(18):2152-2163.
32. Visser W., Friesema E., Jansen J., Visser T. Thyroid hormone transport in and out of cells. Trends Endocrinol Metabol 2008, 19(2):50-56. Review.
33. Wallis K., Sjögren M., van Hogerlinden M., Silberberg G., Fisahn A., Nordström K., Larsson L., Westerblad H., Morreale de Escobar G., Shupliakov O., Vennström B. Locomotor deficiencies and aberrant development of subtype-specific GABAergic interneurons caused by an unliganded thyroid hormone receptor alpha 1. J Neurosci 2008, 28(8):1004-1015.
34. Whybrow P.C., Bauer M. Behavioural and psychiatric aspects of hypothyroidism. The thyroid. A fundamental and clinical text 2005, 842-849. Lippincott - Raven, Philadelphia. 9th edition. L.E. Braverman, R.D. Utiger (Eds.).
35. Yuk D.Y., Lee Y.K., Nam S.Y., Yun Y.W., Hwang D.Y., Choi D.Y., Oh K.W., Hong J.T. Reduced anxiety in the mice expressing mutant (N141I) presenilin 2. J Neurosci Res 2009, 87(2):522-531.